These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9528862)

  • 21. Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs): simple drugs with a complex mechanism of action?
    Normanno N; Maiello MR; De Luca A
    J Cell Physiol; 2003 Jan; 194(1):13-9. PubMed ID: 12447985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced activation of epidermal growth factor receptor caused by tumor-derived E-cadherin mutations.
    Bremm A; Walch A; Fuchs M; Mages J; Duyster J; Keller G; Hermannstädter C; Becker KF; Rauser S; Langer R; von Weyhern CH; Höfler H; Luber B
    Cancer Res; 2008 Feb; 68(3):707-14. PubMed ID: 18245470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential gene expression analysis reveals generation of an autocrine loop by a mutant epidermal growth factor receptor in glioma cells.
    Ramnarain DB; Park S; Lee DY; Hatanpaa KJ; Scoggin SO; Otu H; Libermann TA; Raisanen JM; Ashfaq R; Wong ET; Wu J; Elliott R; Habib AA
    Cancer Res; 2006 Jan; 66(2):867-74. PubMed ID: 16424019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.
    Traxler P; Allegrini PR; Brandt R; Brueggen J; Cozens R; Fabbro D; Grosios K; Lane HA; McSheehy P; Mestan J; Meyer T; Tang C; Wartmann M; Wood J; Caravatti G
    Cancer Res; 2004 Jul; 64(14):4931-41. PubMed ID: 15256466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of p185neu sequences required for monoclonal antibody- or ligand-mediated receptor signal attenuation.
    Qian X; O'Rourke DM; Drebin J; Zhao H; Wang Q; Greene MI
    DNA Cell Biol; 1997 Dec; 16(12):1395-405. PubMed ID: 9428788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trans receptor inhibition of human glioblastoma cells by erbB family ectodomains.
    O'Rourke DM; Qian X; Zhang HT; Davis JG; Nute E; Meinkoth J; Greene MI
    Proc Natl Acad Sci U S A; 1997 Apr; 94(7):3250-5. PubMed ID: 9096379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype.
    Choe G; Park JK; Jouben-Steele L; Kremen TJ; Liau LM; Vinters HV; Cloughesy TF; Mischel PS
    Clin Cancer Res; 2002 Sep; 8(9):2894-901. PubMed ID: 12231534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors.
    Creighton CJ; Hilger AM; Murthy S; Rae JM; Chinnaiyan AM; El-Ashry D
    Cancer Res; 2006 Apr; 66(7):3903-11. PubMed ID: 16585219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of extracellular subdomains of p185c-neu and the epidermal growth factor receptor in ligand-independent association and transactivation.
    Kumagai T; Katsumata M; Hasegawa A; Furuuchi K; Funakoshi T; Kawase I; Greene MI
    Proc Natl Acad Sci U S A; 2003 Aug; 100(16):9220-5. PubMed ID: 12867596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A monoclonal antibody recognizing human cancers with amplification/overexpression of the human epidermal growth factor receptor.
    Jungbluth AA; Stockert E; Huang HJ; Collins VP; Coplan K; Iversen K; Kolb D; Johns TJ; Scott AM; Gullick WJ; Ritter G; Cohen L; Scanlan MJ; Cavenee WK; Old LJ
    Proc Natl Acad Sci U S A; 2003 Jan; 100(2):639-44. PubMed ID: 12515857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Domain-specific interactions between the p185(neu) and epidermal growth factor receptor kinases determine differential signaling outcomes.
    Qian X; O'Rourke DM; Fei Z; Zhang HT; Kao CC; Greene MI
    J Biol Chem; 1999 Jan; 274(2):574-83. PubMed ID: 9872991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Marked inhibition of glioblastoma target cell tumorigenicity in vitro by retrovirus-mediated transfer of a hairpin ribozyme against deletion-mutant epidermal growth factor receptor messenger RNA.
    Halatsch ME; Schmidt U; Bötefür IC; Holland JF; Ohnuma T
    J Neurosurg; 2000 Feb; 92(2):297-305. PubMed ID: 10659018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coexpression of c-erbB 1-4 receptor proteins in human glioblastomas. An immunohistochemical study.
    Torp SH; Gulati S; Johannessen E; Dalen A
    J Exp Clin Cancer Res; 2007 Sep; 26(3):353-9. PubMed ID: 17987795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling.
    Huang HS; Nagane M; Klingbeil CK; Lin H; Nishikawa R; Ji XD; Huang CM; Gill GN; Wiley HS; Cavenee WK
    J Biol Chem; 1997 Jan; 272(5):2927-35. PubMed ID: 9006938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Principles of receptor-based inhibition of erbB family receptor kinases: prospects for new therapies for human cancers.
    O'Rourke DM; Zhang X; Greene MI
    Proc Assoc Am Physicians; 1997 May; 109(3):209-19. PubMed ID: 9154637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soluble LRIG2 ectodomain is released from glioblastoma cells and promotes the proliferation and inhibits the apoptosis of glioblastoma cells in vitro and in vivo in a similar manner to the full-length LRIG2.
    Xiao Q; Tan Y; Guo Y; Yang H; Mao F; Xie R; Wang B; Lei T; Guo D
    PLoS One; 2014; 9(10):e111419. PubMed ID: 25353163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug resistance of human glioblastoma cells conferred by a tumor-specific mutant epidermal growth factor receptor through modulation of Bcl-XL and caspase-3-like proteases.
    Nagane M; Levitzki A; Gazit A; Cavenee WK; Huang HJ
    Proc Natl Acad Sci U S A; 1998 May; 95(10):5724-9. PubMed ID: 9576951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p185neu is expressed in yolk sac during rat postimplantation development.
    Knezevic V; Spaventi R; Poljak L; Slade N; Svajger A; Pavelic K
    J Anat; 1994 Aug; 185 ( Pt 1)(Pt 1):181-7. PubMed ID: 7559112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The extracellular domain of p185(c-neu) induces density-dependent inhibition of cell growth in malignant mesothelioma cells and reduces growth of mesothelioma in vivo.
    Yoneda T; Kumagai T; Nagatomo I; Furukawa M; Yamane H; Hoshino S; Mori M; Takeda Y; Horai T; Nishida S; Watanabe D; Kijima T; Yoshida M; Osaki T; Tachibana I; Greene MI; Kawase I
    DNA Cell Biol; 2006 Sep; 25(9):530-40. PubMed ID: 16989576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical analysis of the mutant epidermal growth factor, deltaEGFR, in glioblastoma.
    Nishikawa R; Sugiyama T; Narita Y; Furnari F; Cavenee WK; Matsutani M
    Brain Tumor Pathol; 2004; 21(2):53-6. PubMed ID: 15700833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.